Shikha Goyal

Dosimetric comparison between Volumetric Modulated Arc Therapy (VMAT) vs Intensity Modulated Radiation Therapy (IMRT) for radiotherapy of mid esophageal carcinoma

AIMS Dosimetric comparison of VMAT with IMRT in middle third esophageal cancer for planning target volume (PTV) and organs at risk (OAR). MATERIALS AND METHODS Ten patients in various stages from I‒III were inducted in the neo-adjuvant chemoradiation protocol for this study. The prescribed dose was 4500 cGy in 25 fractions. Both VMAT and IMRT plan were generated in all cases and Dose Volume Histogram (DVH) comparative analysis was performed for PTV and OAR. Paired t-test was used for statistical analysis. RESULTS The PTV Dmean and D95 in IMRT and VMAT plan were 4566.6±50.6 cGy vs 4462.8±81.8 cGy (P=0.1) and 4379.8±50.6 cGy Vs 4424.3±109.8 cGy (P=0.1), respectively. The CI and HI for PTV in IMRT vs VMAT plans were 0.96±0.02 vs 0.97±0.01 (P=0.4) and 10.58±3.07 vs 9.45±2.42 (P=0.2), respectively. Lung doses for VMAT vs IMRT were 4.19 vs 2.59% (P=0.03) for V35-7.63 vs 4.76% (P=0.01) for V30-13.6 vs 9.98% (P=0.01) for V25-24.77 vs 18.57% (P=0.04) for V20-46.5 vs 34.73% (P=0.002) for V15. The Mean Lung Dose (MLD) was reduced by VMAT technique compared to IMRT; 1524.6±308.37 cGy and 1353±186.32 cGy (P=0.012). There was no change in Dmax to spinal cord in both the techniques. There was a dose reduction by VMAT compared to IMRT to the heart but it was statistically insignificant; V35-6.75% vs 5.55% (P=0.223); V30-12.3% vs 10.91% (P=0.352); V25-21.81% vs 20.16% (P=0.459); V20-38.11% vs 32.88% (P=0.070); V15-61.05% vs 54.2% (P=0.10). CONCLUSION VMAT can be a better option in treating mid esophageal carcinoma as compared to IMRT. The VMAT plans resulted in equivalent or superior dose distribution with a reduction in the dose to lung and heart.

Chemoradiation in elderly patients with head and neck cancers: a single institution experience ☆,☆☆

AIMS To evaluate the efficacy and toxicity of concurrent chemoradiation in patients with head and neck cancers aged 65 and older. MATERIALS AND METHODS Thirty-two elderly patients were treated with radical chemoradiation. Twenty-six (81.3%) out of thirty-two patients had stage III-IV disease. Twenty-nine (90.6%) patients received concurrent weekly cisplatin or carboplatin, 3 (9.4%) patients received concurrent cetuximab or nimotuzumab. Total dose of radiotherapy ranged from 66Gy to 70Gy. RESULTS Twenty-nine patients (90.6%) completed at least 5cycles of concurrent chemotherapy. Twenty-four (77.6%) patients achieved complete response. Fourteen (45.2%) patients experienced grade 3 mucositis. None of our patients developed grade 3 or above hematological toxicity. Loco-regional control and overall survival at 2year were 71.6% and 88.9%, respectively. CONCLUSIONS Chemoradiation in elderly patients with high precision radiotherapy is a feasible option.

Quantification of coronary artery motion and internal risk volume from ECG gated radiotherapy planning scans

BACKGROUND Radiotherapy for carcinoma of breast and thoracic structures involves inadvertent radiation to heart and coronary arteries (CA). Coronary artery stenosis in high radiation dose segments has been documented. Cardiac and respiratory motion induced displacement of CA and internal risk volume (IRV) margin remains inadequately quantified. MATERIAL AND METHODS Twenty cases of carcinoma breast, lung and lung metastasis were enrolled in this study. ECG gated intravenous contrast enhanced computed tomography (CECT) scans were performed in inspiratory breath hold (IBH) and expiratory breath hold (EBH). The images were segregated into inspiratory systole (IS), inspiratory diastole (ID), expiratory systole (ES) and expiratory diastole (ED) sets. Left anterior descending (LAD), limited segment of LAD close to chest wall (short LAD), right coronary artery (RCA), Left circumflex artery (LCX) and left ventricle (LV) were delineated in all four sets. Mean displacements in systole versus diastole and inspiration versus expiration were calculated in three co-ordinates [anterio-posterior (Z), left-right (X) and cranio-caudal (Y)]. RESULTS Mean of displacement (mm) between systole and diastole (IS versus ID; and ES versus ED) in X, Y, Z co-ordinates were: LAD 3.0(±1.6), 2.8(±1.5), 3.6(±2.0); Short-LAD 3.0(±1.1), 0.8(±0.4), 2.4(±0.6); LV 2.4(±1.6), 1.7(±1), 5.0(±1.5); LCX 4.9(±1.6), 2.9(±1.3), 5.1(±1.9); RCA 6.6(±2.2), 3.6(±2.1), 5.9(±2.2). Mean displacement between inspiration and expiration (IS versus ES; and ID versus ED) in X, Y, Z axes were: LAD 3.3(±1.5), 8.0(±3.4), 3.8(±1.8); Short-LAD 2.7(±1), 12.2(±4.4), 3.3(±1.5); LV 2.9(±1.4), 9.8(±3.3), 4.7(±1.9); LCX 2.9(±.8), 9.7(±3.2), 6.2(±2.5); RCA 2.6(±1.3), 7.6(±2.5), 3.8(±1.7). CONCLUSION Radial (RM), cranio-caudal margin (CC) of 7mm, 4mm in breath-hold radiotherapy whereas RM, CC of 7mm, 13mm respectively in free breath radiotherapy will cover the range of motions of CA, LV and can be recommended as IRV for these structures.

Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents.

PURPOSE To analyze incidental radiation doses to minimally dissected axilla with Intensity modulated radiotherapy (IMRT), 3D conformal radiotherapy (3DCRT) and standard tangents (ST). METHODS & MATERIALS We prospectively evaluated incidental radiation to axilla in fifty cases of early breast cancer treated with breast conservation surgery with sentinel node biopsy alone followed by whole breast irradiation with IMRT. Three plans were devised for each CT dataset, comprising ST, 3DCRT and IMRT tangents. Doses to axillary nodal levels I, II and III were evaluated for mean dose, V95, V90, V80 and V50. Comparisons were made using ANOVA. RESULTS The mean doses delivered to axilla by the three techniques (IMRT, 3DCRT, ST) were: 78% (range 67-90, SD ± 5.2%), 80% (63-95, ±7.5%) and 87% (73-98, ±4.8%) for level I (IMRT vs ST; p = 0.037); 70% (46-89, ±12.4%), 72% (34-93, ±15.5%) and 65% (29-87, ±11.8%) for level II; and 51% (28-76, ±11.1%), 53% (19-86, ±13.7%) and 41% (6-72, ±10.6%) for level III, respectively. V90 values (volume receiving 90% of dose) for the three techniques were 49% (43-53, ±2.7%), 57% (51-65, ±3.1%) and 73% (65-80, ±3.4%) for level I (IMRT vs. ST; p = 0.029); 35% (26-42, ±4.7%), 41% (33-50, ±4.2%) and 25% (17-36, ±4.5%) for level II (IMRT vs ST; p = 0.068); and 15% (9-22, ±3.4%), 16% (10-24, ±3.7%) and 8 (5-12, ±3.1%) for level III (IMRT vs ST; p = 0.039), respectively. CONCLUSION Axillary levels I and II (lower axilla) receive substantial amount of incidental radiation doses with all the three techniques; however, conformal techniques (IMRT, 3DCRT) deliver significantly lesser incidental radiation to lower axilla than ST technique.

Parotid metastasis from carcinoma urinary bladder treated with CyberKnife-based stereotactic body radiotherapy: case report and review of literature

Abstract Metastasestotheparotidregionarerelativelyinfrequentandoriginateprimarilyfromheadandneckcancer.Metastases of an infraclavicular origin are uncommon. Moreover, metastasis from the carcinoma of urinarybladder (CUB) to any part of the head and neck, including parotid gland, is rare. Surgery and chemotherapyare usually offered. We report a case of solitary parotid metastasis from CUB, who was successfully treatedwith stereotactic body radiotherapy (SBRT) using CyberKnife. SBRT is a safe alternative in cases unwilling/unfit for surgery. Keywords: carcinoma urinarybladder;CyberKnife;parotid metastasis; stereotactic body radiotherapyINTRODUCTIONMetastases to the parotid region are relativelyinfrequent andoriginate primarilyfrom head andneck cancer. 1 Metastases of an infraclavicularorigin are uncommon. 2 Moreover, metastasisfromthecarcinomaofurinarybladder(CUB)toanypart of the head and neck, including parotid gland,is rare. 3 Surgery and chemotherapy are usuallyoffered.Thisreportdescribesacaseofsolitaryparotidmetastasis from CUB, who was successfully treatedwith stereotactic body radiotherapy (SBRT) usingCyberKnife. To the best of our knowledge, this isthe first documented case of parotid metastasis fromtransitional cell CUB treated by SBRT.CASE HISTORYA 79-year-old gentleman was operated for CUBin December 2011 and the tumour was staged aspT4pN0cM0 after radical cystectomy. He wasfree from disease recurrence on routine cysto-scopy and [

PO-0883: Quantification of Duodenum motion: analysis from respiratory phase guided radiotherapy planning scan

Material and Methods: We studied 12 healthy volunteers (4 males), with a mean age of 33 y, mean height of 172 cm, mean weight of 63 kg and a mean vital capacity of 3.2 L. Each attempted to perform three 1-minute BHs in end-inhale (completely inflated lungs), deep-inhale (lung volume of ~70%), deep-exhale (lung volume of ~30%) and end-exhale (completely deflated lungs). During BH, we used a 3T MRI to dynamically (1.7 Hz) acquire a thick (8 mm) high resolution (0.9×0.9 mm2) 2D coronal slice including both the pancreatic head and the diaphragm. For each BH, the motion (i.e. displacement in all successive images relative to the first image) of the pancreatic head and of the diaphragm in the inferior-superior (IS) direction was determined using a 2D image correlation algorithm. The Wilcoxon signed-rank test was used to test the differences in maximum displacement during BH between the different BH types. To investigate the correlation between the intra-BH motion of the pancreas and of the diaphragm, we determined the Pearson correlation coefficient (r). As the achieved BH duration varied, only the data acquired during the first 30 seconds of each BH were included in our analysis.

Need of collaborative radiology–radiation oncology workshops in decision making for head and neck cancer (HNC) management in India: Perspectives of the radiation oncologists

BACKGROUND In India, head and neck cancer (HNC) has always been a challenge to treatment due to its various disease., treatment., and patient.related factors. Recent developments in the field of both radiology and radiation oncology brings us to a stage where combined collaborative efforts are required for proper management of HNC. The article identifies the potential areas of such need through online survey. MATERIALS AND METHODS This anonymous online survey with specific questions and their responses from radiation oncology community identifies potential areas of radiology expertise as perceived by a radiation oncologist. The questions were simple Likert-type and the best possible response was sought for. RESULTS There were 57 email responses and majority (37) agreed upon the extreme importance of such collaborative efforts. The major areas where a radiation oncologist would seek help are target volume delineation and response evaluation posttreatment in HNC, though other areas are also important albeit to a lesser degree. CONCLUSION There is urgent need of radiology.radiation oncology workshops in managing HNC in the modern era of image.based and image-guided treatment. Future larger hospital.based survey would determine need on a large scale basis at resolving these issues.

Do we need to spare central nervous system structures during head and neck cancer intensity modulated radiotherapy

Introduction: Fatigue has always been a distressing symptom for patients of head and neck cancer (HNC) on radiotherapy. Although modern technologies like intensity modulated radiotherapy (IMRT) have been instrumental in reducing many of the distressing side-effects but the recent observation of increased fatigue has been a concern. Recent publications though very few hinted at possible correlation with dosage to central nervous system (CNS) structures. The current resource review highlights a very preliminary example of a futuristic approach. Materials and Methods: This retrospective analysis comprising of 20 HNC patients receiving either postoperative or radical radiotherapy by IMRT were evaluated with CNS dosage. The main organs contoured in planning computed tomography (CT) scan were brainstem (BS) and posterior fossa (PF) excluding BS. The dose received to these organs was recorded. The literature reported CNS structure dosage, which can probably cause increased fatigue was assessed. Results: Among the 20 nonnasopharyngeal HNC, 13 received radical radiotherapy and 7 had postoperative radiotherapy. Six patients had treatment gap varying between 2 and 10 days, mostly due to hematological toxicities and oral mucositis. The median volumes of PF and BS were 263.5 and 25.1 cc. Dmax for BS and PF ranged between 4.8 and 44.76 Gy and 23.8-63.2 Gy and the median Dmean for PF was 8.89 Gy. Conclusion: Future prospective analysis with inclusion of modified brief fatigue inventory scale and dosimetric evaluation of CNS structures would probably answer the necessity of sparing CNS structures and spare patients from excessive fatigue and related consequences.

Stereotactic body radiotherapy with CyberKnife in solitary adrenal metastasis

Metastases to adrenal glands from solid tumors are fairly common. The incidence varies from 17.6% to 35% in lung primaries and 13-27% in other malignancies. Most of these lesions are clinically occult. Historically, the role of radiotherapy was limited to palliation of pain in symptomatic lesions. However, with the advent of more conformal techniques such as stereotactic body radiation therapy, the focus has shifted to treatment of such lesions with curative intent in selected situations. We treated a patient of non-small cell lung cancer with solitary adrenal metastasis, following partial response to chemotherapy. The adrenal lesion was treated with CyberKnife while the lung lesion was treated with intensity modulated radiotherapy, both with curative intent.